Althea's Express Pathway senior team combines over 100 years of relevant experience to enable a vertically integrated biomarker discovery and development company with requisite scientific and operational disciplines, from quantification of a disease-specific genomic target through introduction of a clinically relevant diagnostic panel for routine laboratory analysis.

Having our roots in molecular biology and manufacturing of biologics, there is particular depth in real-time and quantitative PCR-based RNA and DNA analysis, SNP-analysis, RNA extraction, and full GLP-compliant facilities.